newsfilter
← Latest News
GlobeNewswire·

Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly

REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy as a potential One And DoneTM treatment to